BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29386142)

  • 1. Oncocytic tumors are marked by enhanced mitochondrial content and mtDNA mutations of complex I in Chinese patients.
    Lyu L; Wang Q; Song S; Li L; Zhou H; Li M; Jiang Z; Zhou C; Chen G; Lyu J; Bai Y
    Mitochondrion; 2019 Mar; 45():1-6. PubMed ID: 29386142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.
    Gasparre G; Porcelli AM; Bonora E; Pennisi LF; Toller M; Iommarini L; Ghelli A; Moretti M; Betts CM; Martinelli GN; Ceroni AR; Curcio F; Carelli V; Rugolo M; Tallini G; Romeo G
    Proc Natl Acad Sci U S A; 2007 May; 104(21):9001-6. PubMed ID: 17517629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
    Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
    J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.
    Lang M; Vocke CD; Merino MJ; Schmidt LS; Linehan WM
    Mod Pathol; 2015 Nov; 28(11):1458-69. PubMed ID: 26428318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
    Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
    Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
    Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
    Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors.
    Zimmermann FA; Mayr JA; Feichtinger R; Neureiter D; Lechner R; Koegler C; Ratschek M; Rusmir H; Sargsyan K; Sperl W; Kofler B
    Front Biosci (Elite Ed); 2011 Jan; 3(1):315-25. PubMed ID: 21196312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
    Evangelisti C; de Biase D; Kurelac I; Ceccarelli C; Prokisch H; Meitinger T; Caria P; Vanni R; Romeo G; Tallini G; Gasparre G; Bonora E
    BMC Cancer; 2015 Mar; 15():157. PubMed ID: 25880213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.
    Pereira L; Soares P; Máximo V; Samuels DC
    BMC Cancer; 2012 Feb; 12():53. PubMed ID: 22299657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas.
    Kurelac I; MacKay A; Lambros MB; Di Cesare E; Cenacchi G; Ceccarelli C; Morra I; Melcarne A; Morandi L; Calabrese FM; Attimonelli M; Tallini G; Reis-Filho JS; Gasparre G
    Hum Mol Genet; 2013 Jan; 22(2):226-38. PubMed ID: 23049073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
    Mayr JA; Meierhofer D; Zimmermann F; Feichtinger R; Kögler C; Ratschek M; Schmeller N; Sperl W; Kofler B
    Clin Cancer Res; 2008 Apr; 14(8):2270-5. PubMed ID: 18413815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors.
    Mussazhanova Z; Shimamura M; Kurashige T; Ito M; Nakashima M; Nagayama Y
    Cancer Sci; 2020 Aug; 111(8):2814-2823. PubMed ID: 32458504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations.
    Corver WE; van Wezel T; Molenaar K; Schrumpf M; van den Akker B; van Eijk R; Ruano Neto D; Oosting J; Morreau H
    Genes Chromosomes Cancer; 2014 Oct; 53(10):833-44. PubMed ID: 24909752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid.
    Mussazhanova Z; Akazawa Y; Matsuda K; Shichijo K; Miura S; Otsubo R; Oikawa M; Yoshiura K; Mitsutake N; Rogounovitch T; Saenko V; Kozykenova Z; Zhetpisbaev B; Shabdarbaeva D; Sayakenov N; Amantayev B; Kondo H; Ito M; Nakashima M
    Endocr J; 2016 May; 63(5):457-67. PubMed ID: 26935218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer.
    Fang H; Shen L; Chen T; He J; Ding Z; Wei J; Qu J; Chen G; Lu J; Bai Y
    BMC Cancer; 2010 Aug; 10():421. PubMed ID: 20704735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.
    Conti L; Vatrano S; Bertero L; Masu L; Pacchioni D; Daniele L; De Rosa G; Cassoni P; Volante M; Papotti M
    Hum Pathol; 2017 Nov; 69():23-30. PubMed ID: 28962946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mitochondrial DNA mutations associated with Chinese familial hypertrophic cardiomyopathy.
    Wei YL; Yu CA; Yang P; Li AL; Wen JY; Zhao SM; Liu HX; Ke YN; Campbell W; Zhang YG; Li XH; Liao WQ
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):933-9. PubMed ID: 19473338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular features of thyroid oncocytic tumors.
    Gasparre G; Bonora E; Tallini G; Romeo G
    Mol Cell Endocrinol; 2010 May; 321(1):67-76. PubMed ID: 20184940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
    Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
    Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration.
    Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S
    PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.